Fauna Bio

6460 Hollis St. Ste. A


Rather than just relying on gene targets within people, which can be sparse and difficult to find, Fauna Bio takes a broad approach within the animal kingdom. Extreme adaptation is common across many mammals, giving a vast pool of potential targets. Whereas a single heart attack can kill a person, certain animals not only survive 25 heart attacks a year but also go on to thrive, living two-times longer than others their size. By identifying and understanding the protective physiological mechanisms that enable this survival, Fauna Bio can rapidly develop novel treatments.

Fauna Bio is addressing a $60+ billion potential market with first targets in heart disease, stroke, Alzheimer’s and diabetes.